GSK plc (GSK)$51.38
Market Cap: 78.98 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for GSK plc (GSK).
HEALTHCARE
DRUG MANUFACTURERS - GENERAL
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
N/A
ROIC, N/A FCF margin
Growth
N/A
5Y sales (revenue) CAGR
Balance sheet
N/A
Debt/equity, N/A current ratio
Superinvestors
5
Top: Hillman Value Fund (3.7%)
Strengths to research
No strong positive screening signals were detected from the checked-in dataset.
Watchouts
- Full metrics are not available yet for this ticker.
Annual data: 0 periods
Quarterly data: 5 periods
Stock snapshot: May 24, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for GSK.
Grade F
0
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| GSK Target | GSK plc | $79.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| BMY | Bristol-Myers Squibb | $101.9B | 17.2x | 10.6x | 11.1% | 2.5% | 26.7% | N/A | N/A | N/A |
| GILD | Gilead Sciences | $128.0B | 19.8x | 15.4x | 17.9% | 3.6% | 32.1% | N/A | 1.7x | N/A |
| SNY | Sanofi Aventis | $133.3B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| PFE | Pfizer Inc. | $135.4B | 19.0x | 14.8x | 9.0% | 8.5% | 14.5% | N/A | N/A | N/A |
| AMGN | Amgen | $150.6B | 23.8x | 24.2x | 12.2% | 7.6% | 22.0% | N/A | 3.2x | N/A |
| MRK | Merck & Co. | $208.5B | 16.8x | 15.7x | 34.7% | 9.4% | 19.0% | N/A | N/A | N/A |
| NVS | Novartis AG | $223.3B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| BAYRY | Bayer Ag Sponsored ADR | $26.9B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Financial Charts
No financial data available for GSK (annual).
5 superinvestors own GSK
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 58,662,974 | $3.2B | 1.78% | 0.0% |
| Kahn Brothers Group Kahn Brothers Group | 160,982 | $9M | 1.58% | 0.0% |
| Hillman Value Fund Hillman Value Fund | 97,432 | $5M | 3.73% | 0.0% |
| Tweedy Browne Co. Tweedy Browne Value Fund | 81,785 | $5M | 0.36% | 0.0% |
| Richard Pzena Hancock Classic Value | 18,823 | $1M | 0.00% | 0.0% |